XML 83 R67.htm IDEA: XBRL DOCUMENT v3.10.0.1
Composition of Total Revenue - Schedule of Net Product Sales by Product Line (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Segment Reporting Information [Line Items]                      
Total revenues $ 29,402 $ 25,268 $ 24,168 $ 30,495 $ 28,570 $ 36,395 $ 34,301 $ 29,101 $ 109,333 $ 128,367 $ 146,444
Product [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 104,466 116,178 128,596
FOLOTYN [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 47,981 43,015 46,245
EVOMELA [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 28,292 35,178 16,169
Beleodaq [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 12,328 12,353 13,368
ZEVALIN [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 7,044 11,759 10,730
MARQIBO [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 5,502 6,573 7,245
Fusilev [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 2,437 7,300 34,839
KHAPZORY [Member]                      
Segment Reporting Information [Line Items]                      
Total revenues                 $ 882 $ 0 $ 0
Product Concentration Risk [Member] | Sales [Member] | Product [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 100.00% 100.00% 100.00%
Product Concentration Risk [Member] | Sales [Member] | FOLOTYN [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 45.90% 37.00% 36.00%
Product Concentration Risk [Member] | Sales [Member] | EVOMELA [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 27.10% 30.30% 12.60%
Product Concentration Risk [Member] | Sales [Member] | Beleodaq [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 11.80% 10.60% 10.40%
Product Concentration Risk [Member] | Sales [Member] | ZEVALIN [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 6.70% 10.10% 8.30%
Product Concentration Risk [Member] | Sales [Member] | MARQIBO [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 5.30% 5.70% 5.60%
Product Concentration Risk [Member] | Sales [Member] | Fusilev [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 2.30% 6.30% 27.10%
Product Concentration Risk [Member] | Sales [Member] | KHAPZORY [Member]                      
Segment Reporting Information [Line Items]                      
Percentage of sales                 0.80% 0.00% 0.00%